Applied Genetic Technologies (AGTC) Misses Q1 EPS by 5c; Reports Cash and Cash Equivalents of $90.5M
Tweet
Share
E-mailGet Alerts AGTC Hot Sheet
Join SI Premium – FREE
Applied Genetic Technologies (NASDAQ: AGTC) reported Q1 EPS of ($0.40), $0.05 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
